Samsung Biologics Co.,Ltd.
207940
Rang în acțiuni
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Preț acțiune
$1,028.49
Capitalizare de piață
$47.88B
Schimbare (1 zi)
-3.67%
Schimbare (1 an)
-18.37%
Țară
KR
Tranzacționează Samsung Biologics Co.,Ltd. (207940)
Categorie
Healthcare
Raport P/B pentru Samsung Biologics Co.,Ltd. (207940)
Raport P/B la data de October 2026 TTM: 7.59
Conform celor mai recente rapoarte financiare și prețului acțiunilor Samsung Biologics Co.,Ltd., raportul P/B actual (TTM) este 7.59. La sfârșitul anului 2024, compania avea un P/B de 6.19.
Istoricul raportului P/B pentru Samsung Biologics Co.,Ltd. din 2014 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 7.59 | -27.89% |
| 2025 | 10.52 | 69.82% |
| 2024 | 6.19 | 8.43% |
| 2023 | 5.71 | -11.02% |
| 2022 | 6.42 | -46.93% |
| 2021 | 12.10 | 0.73% |
| 2020 | 12.01 | 80.63% |
| 2019 | 6.65 | 10.48% |
| 2018 | 6.02 | -8.12% |
| 2017 | 6.55 | 197.83% |
| 2016 | 2.20 | -43.49% |
| 2015 | 3.89 | -78.44% |
| 2014 | 18.05 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| 6.6964 | -11.72% |
US
|
|
| 13.6307 | 79.69% |
US
|
|
| 4.4521 | -41.31% |
AU
|
|
| 4.2241 | -44.31% |
BE
|
|
| 6.3632 | -16.11% |
NL
|
